VWM
SRNE

Vermillion Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Vermillion Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-70
Closed – – 698
2025
Q3 		$0 Buy
+70
New – ﹤0.01% 1545
2025
Q2 		– Sell
-70
Closed – – 596
2025
Q1 		$0 Buy
+70
New – ﹤0.01% 1343

Other funds holding SRNE

KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
OC
Oakworth Capital Birmingham, Alabama $2.1B AUM 24.07% 1-Year Est. Return

Vermillion Wealth Management's SRNE Position: Q4 2025 in Review

Vermillion Wealth Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2025, closing a stake of 70 shares.

Vermillion Wealth Management first reported a position in SRNE in Q1 2025 and held it in 2 quarters. The position peaked at $0 in Q3 2025. 5 funds tracked by Wall St. Rank hold SRNE as of Q4 2025.

  • Vermillion Wealth Management reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2025 after selling out during the quarter.
  • Vermillion Wealth Management sold 70 Sorrento Therapeutics, Inc. shares in Q4 2025.
  • Vermillion Wealth Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2025 and held it in 2 quarters.
  • Vermillion Wealth Management's Sorrento Therapeutics, Inc. position peaked at $0 in Q3 2025.
  • 5 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2025.

Based on Vermillion Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.